Tianjin TEDA Biomedical Engineering Company Limited
HKEX:8189.HK
0.21 (HKD) • At close September 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 397.998 | 449.676 | 476.385 | 369.355 | 358.752 | 351.898 | 375.907 | 389.278 | 501.59 | 552.041 | 583.112 | 677.64 | 511.151 | 429.057 | 432 | 422.512 | 327.955 | 270.639 | 205.032 |
| Cost of Revenue
| 376.632 | 433.281 | 430.78 | 328.963 | 323.756 | 350.191 | 322.701 | 310.473 | 404.869 | 437.446 | 452.527 | 541.304 | 411.882 | 345.68 | 346.253 | 355.949 | 277.316 | 227.014 | 173.701 |
| Gross Profit
| 21.366 | 16.395 | 45.605 | 40.392 | 34.996 | 1.707 | 53.205 | 78.806 | 96.721 | 114.595 | 130.585 | 136.336 | 99.268 | 83.377 | 85.747 | 66.563 | 50.639 | 43.625 | 31.331 |
| Gross Profit Ratio
| 0.054 | 0.036 | 0.096 | 0.109 | 0.098 | 0.005 | 0.142 | 0.202 | 0.193 | 0.208 | 0.224 | 0.201 | 0.194 | 0.194 | 0.198 | 0.158 | 0.154 | 0.161 | 0.153 |
| Reseach & Development Expenses
| 1.319 | 1.136 | 3.499 | 5.516 | 8.298 | 11.667 | 9.294 | 11.499 | 15.416 | 11.068 | 20.962 | 17.961 | 12.066 | 14.351 | 11.52 | 2.774 | 7.298 | 3.376 | 1.287 |
| General & Administrative Expenses
| 21.804 | 26.972 | 31.467 | 23.66 | 27.607 | 32.195 | 36.228 | 30.74 | 21.508 | 28.805 | 28.996 | 36.204 | 27.015 | 22.777 | 28.731 | 33.256 | 19.023 | 26.165 | 18.32 |
| Selling & Marketing Expenses
| 8.102 | 10.517 | 17.289 | 16.674 | 18.561 | 21.727 | 14.756 | 20.496 | 23.515 | 39.596 | 46.337 | 43.898 | 39.841 | 38.636 | 39.006 | 30.979 | 24.819 | 20.795 | 19.532 |
| SG&A
| 29.906 | 37.489 | 48.756 | 40.334 | 46.168 | 53.922 | 50.984 | 51.236 | 45.023 | 68.401 | 75.333 | 80.102 | 66.856 | 61.414 | 67.737 | 64.235 | 43.842 | 46.961 | 37.852 |
| Other Expenses
| -0.316 | -0.114 | -0.497 | -0.582 | 1.139 | 0.946 | -1.165 | -0.871 | 0.904 | -0.031 | 0 | -0.062 | -5.071 | -4.279 | -4.931 | -3.794 | -0.794 | 3.126 | 2.047 |
| Operating Expenses
| 31.201 | 38.511 | 51.757 | 45.268 | 55.605 | 64.55 | 59.113 | 61.864 | 61.343 | 79.438 | 96.295 | 98.001 | 73.851 | 71.486 | 74.327 | 63.215 | 50.346 | 44.091 | 32.11 |
| Operating Income
| -19.337 | -20.805 | -4.445 | -21.749 | -27.931 | -59.541 | -9.92 | 13.027 | 35.619 | 35.205 | 32.354 | 38.625 | 25.417 | 11.891 | 11.421 | 4.531 | -0.329 | 3.166 | 2.022 |
| Operating Income Ratio
| -0.049 | -0.046 | -0.009 | -0.059 | -0.078 | -0.169 | -0.026 | 0.033 | 0.071 | 0.064 | 0.055 | 0.057 | 0.05 | 0.028 | 0.026 | 0.011 | -0.001 | 0.012 | 0.01 |
| Total Other Income Expenses Net
| 7.324 | -5.69 | -40.394 | -28.251 | -60.885 | -240.939 | -10.537 | -3.581 | -3.669 | -8.42 | -7.606 | -7.697 | -6.415 | -3.913 | -6.735 | -10.48 | -10.343 | -0.601 | -3.454 |
| Income Before Tax
| -12.012 | -26.495 | -44.839 | -50.001 | -88.816 | -300.479 | -20.457 | 9.446 | 31.949 | 26.785 | 24.747 | 30.928 | 19.002 | 7.978 | 4.686 | -5.949 | -10.671 | 2.565 | -1.431 |
| Income Before Tax Ratio
| -0.03 | -0.059 | -0.094 | -0.135 | -0.248 | -0.854 | -0.054 | 0.024 | 0.064 | 0.049 | 0.042 | 0.046 | 0.037 | 0.019 | 0.011 | -0.014 | -0.033 | 0.009 | -0.007 |
| Income Tax Expense
| -1.044 | 0.151 | -0.055 | 0.363 | -0.005 | 0.159 | 0.827 | 4.496 | 4.502 | 7.826 | 2.606 | 6.71 | 2.688 | -0.015 | 0.611 | 2.269 | 1.077 | 0.326 | 0.244 |
| Net Income
| -20.16 | -26.646 | -44.784 | -50.363 | -88.811 | -177.68 | -13.752 | 5.971 | 25.565 | 17.787 | 21.374 | 24.017 | 14.417 | 6.142 | 5.149 | -8.988 | -11.377 | 3.034 | 0.773 |
| Net Income Ratio
| -0.051 | -0.059 | -0.094 | -0.136 | -0.248 | -0.505 | -0.037 | 0.015 | 0.051 | 0.032 | 0.037 | 0.035 | 0.028 | 0.014 | 0.012 | -0.021 | -0.035 | 0.011 | 0.004 |
| EPS
| -0.011 | -0.014 | -0.024 | -0.027 | -0.047 | -0.096 | -0.008 | 0.004 | 0.017 | 0.013 | 0.015 | 0.017 | 0.01 | 0.004 | 0.005 | -0.014 | -0.019 | 0.005 | 0.002 |
| EPS Diluted
| -0.011 | -0.014 | -0.024 | -0.027 | -0.047 | -0.096 | -0.008 | 0.004 | 0.017 | 0.013 | 0.015 | 0.017 | 0.01 | 0.004 | 0.005 | -0.014 | -0.019 | 0.005 | 0.002 |
| EBITDA
| 1.733 | -5.415 | 5.068 | -14.645 | -13.324 | -35.49 | 10.461 | 21.7 | 46.456 | 44.602 | 41.609 | 47.695 | 35.679 | 21.369 | 21.152 | 13.834 | 6.218 | 8.717 | 6.257 |
| EBITDA Ratio
| 0.004 | -0.012 | 0.011 | -0.04 | -0.037 | -0.101 | 0.028 | 0.056 | 0.093 | 0.081 | 0.071 | 0.07 | 0.07 | 0.05 | 0.049 | 0.033 | 0.019 | 0.032 | 0.031 |